Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Amortizatization of Intangibles: 2022-2024

Historic Amortizatization of Intangibles for Mereo BioPharma Group (MREO) over the last 3 years, with Dec 2024 value amounting to $507,000.

  • Mereo BioPharma Group's Amortizatization of Intangibles rose 3.10% to $133,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $521,000, marking a year-over-year increase of 3.17%. This contributed to the annual value of $507,000 for FY2024, which is 2.42% up from last year.
  • As of FY2024, Mereo BioPharma Group's Amortizatization of Intangibles stood at $507,000, which was up 2.42% from $495,000 recorded in FY2023.
  • Mereo BioPharma Group's 5-year Amortizatization of Intangibles high stood at $708,000 for FY2022, and its period low was $495,000 during FY2023.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $507,000 (2024), whereas its average is $570,000.
  • As far as peak fluctuations go, Mereo BioPharma Group's Amortizatization of Intangibles slumped by 30.08% in 2023, and later climbed by 2.42% in 2024.
  • Yearly analysis of 3 years shows Mereo BioPharma Group's Amortizatization of Intangibles stood at $708,000 in 2022, then plummeted by 30.08% to $495,000 in 2023, then grew by 2.42% to $507,000 in 2024.